cloudhosting14 wrote: As you would already know that managed hosting itself is another form of Cloud hosting in which the system administrations of servers is looked upon by the CPs. Similar is the case with managed multi Cloud hosting. You can very well understand how a big burden it would be to manage multi cloud servers for organization; this is why a service known as managed multi Cloud is provided to these users. This service ensures them the seam less running of their system administrative operations while organizations focus more on t...
In many cases, the end of the year gives you time to step back and take stock of the last 12 months. This is when many of us take a hard look at what worked and what did not, complete performance reviews, and formulate plans for the coming year. For me, it is all of those things plus a time when I u...
NYSE Euronext (NYX) today announced trading volumes for its global
derivatives and cash equities exchanges for December 20121.
Global derivatives average daily volume (“ADV”) of 7.5 million contracts
in December 2012 was down slightly compared to December 2011 and
decreased 8.0% from November 2012 levels on seasonally slower trading
activity. European derivatives fixed income ADV, however, increased
17.4% from December 2011 levels. Trading volumes in European and U.S.
equities, declined both year-over-year and month-over-month.
Highlights
NYSE Euronext global derivatives ADV in December 2012 of 7.5 million
contracts decreased 0.2% compared to December 2011, and decreased 8.0%
from November 2012 levels.
NYSE Euronext European derivatives products ADV in December 2012 of
3.5 million contracts increased 1.5% compared to December 2011, but
decreased 12.4% from November 2012 levels. Excluding Bclear, NYSE
Liffe's trade administration and clearing service for OTC products,
European derivatives products ADV increased 8.5% compared to December
2011 and increased 1.5% from November 2012.
NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex Options)
ADV of 3.9 million contracts in December 2012 decreased 1.2% compared
to December 2011 levels, and decreased by 4.4% from November 2012
levels. NYSE Euronext’s U.S. options exchanges accounted for 27.2% of
total U.S. consolidated equity options trading in December 2012, down
from 27.7% in December 2011 and down from 28.1% in November 2012.
NYSE Liffe U.S. ADV of approximately 72,600 contracts decreased from
89,600 contracts in December 2011, but increased from 51,500 contracts
in November 2012.
NYSE Euronext European cash products ADV of 1.1 million transactions
in December 2012 decreased 20.2% compared to December 2011 and
decreased 8.7% compared to November 2012.
NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE-MKT)
handled ADV of 1.5 billion shares in December 2012 decreased 14.7%
compared to December 2011 and decreased 3.4% compared to November
2012. NYSE Euronext’s Tape A matched market share in December 2012 was
31.9%, down from 33.4% in December 2011, but up from 31.7% in November
2012.
The preliminary average net revenue per transaction type (as defined
below) for each of the primary trading venues in the fourth quarter of
2012 is included below:
Preliminary
Trading Venue
4Q11
3Q12
4Q12
European Derivatives (ex. Bclear)1
$0.698
$0.657
$0.67
U.S. Derivatives2
$0.148
$0.144
$0.14
European Cash3
$0.582
$0.537
$0.58
U.S. Cash4
$0.039
$0.040
$0.040
1 Average net revenue per contract, excluding
Bclear.
2 Average net revenue per contract. Excludes
NYSE Liffe U.S. trading volume.
3 Average net revenue per transaction.
4 Average net revenue per 100 shares handled.
Derivatives Trading
European Derivatives
NYSE Euronext European derivatives products ADV in December 2012 was
3.5 million futures and options contracts, an increase of 1.5% from
December 2011, but a decrease of 12.4% from November 2012.
The 3.5 million in European derivatives futures and options contracts
ADV in December 2012 consisted of 2.4 million contracts executed
through our full-service LIFFE CONNECT trading platform and 1.1
million contracts, or 31.6%, executed through Bclear, NYSE Liffe's
trade administration and clearing service for OTC products. Excluding
Bclear, European derivatives products ADV increased 8.5% compared to
December 2011 and increased 1.5% from November 2012.
In the fourth quarter of 2012, European derivatives products ADV of
3.5 million contracts was 2.3% below prior year levels. The 3.5
million in futures and options contracts ADV in the fourth quarter of
2012 consisted of 2.3 million contracts executed through LIFFE CONNECT
trading platform and 1.2 million contracts, or 33.7%, executed through
Bclear.
For the full-year 2012, European derivatives products ADV of 3.7
million contracts was 16.8% below prior year levels. The 3.7 million
in futures and options contracts ADV year-to-date consisted of 2.6
million contracts executed through LIFFE CONNECT trading platform and
1.1 million contracts, or 29.7%, executed through Bclear.
Total fixed income products ADV of 1.6 million contracts in December
2012 increased 17.4% from December 2011 and increased 0.3% from
November 2012. In the fourth quarter of 2012, total fixed income
products ADV of 1.6 million contracts was 13.3% below prior year
levels. For the full-year 2012, total fixed income products ADV of 1.8
million contracts was 22.0% below prior year levels.
Total equity products (including Bclear) ADV of 1.8 million contracts
in December 2012 decreased 10.6% compared to December 2011 and
decreased 21.9% from November 2012. The 1.8 million contracts in
equity products ADV consisted of 1.3 million contracts in individual
equity products ADV and 0.5 million contracts in equity index products
ADV. The 1.3 million contracts in individual equity products ADV
consisted of 0.9 million in futures contracts, which represented a
14.0% decrease compared to December 2011 and 0.4 million in options
contracts, which represented a 17.9% decrease compared to December
2011. In the fourth quarter of 2012, total equity products ADV of 1.9
million contracts were 7.6% below prior year levels. For the full-year
2012, total equity products ADV of 1.9 million contracts were 12.3%
below prior year levels.
Total commodities products ADV of 97,000 contracts in December 2012
increased 43.3% compared to December 2011 and increased 12.5% compared
to November 2012. In the fourth quarter of 2012, total commodities
product ADV of 96,500 contracts was 34.3% above prior year levels. For
the full-year 2012, total commodities product ADV of 89,000 contracts
was 10.6% above prior year levels.
U.S. Derivatives
NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex Options)
ADV of 3.9 million contracts in December 2012 decreased 1.2% compared
to December 2011 and decreased 4.4% compared to November 2012. In the
fourth quarter of 2012, U.S. equity options ADV of 4.0 million
contracts was 6.7% below prior year levels. For the full-year 2012,
U.S. equity options ADV of 3.9 million contracts was 11.6% below prior
year levels.
Total U.S. consolidated equity options ADV increased 0.4% to 14.3
million contracts in December 2012 compared to December 2011, but
decreased 1.5% compared to November 2012. In the fourth quarter of
2012, U.S. consolidated equity options ADV of 14.3 million contracts
was 7.6% below prior year levels. For the full-year 2012, U.S.
consolidated equity options ADV of 14.7 million contracts was 12.2%
below prior year levels.
NYSE Euronext’s U.S. options exchanges accounted for 27.2% of the
total U.S. consolidated equity options trading in December 2012, down
from 27.7% in December 2011 and down slightly from a record 28.1% in
November 2012.
NYSE Liffe U.S. ADV of approximately 72,600 contracts decreased from
89,600 contracts in December 2011, but increased from 51,500 contracts
in November 2012. In December 2012, the mini MSCI Index futures traded
a record ADV of 41,570 contracts, an increase of 108% compared to
December 2011, and open interest across the entire MSCI complex hit an
all time high on December 19, 2012 of 267,932 contracts. In the fourth
quarter of 2012, U.S. futures and futures options ADV of 55,200
contracts was 39.4% below prior year levels. For the full-year 2012,
U.S. futures and futures options ADV of 72,700 contracts was 10.4%
below prior year levels.
Cash Trading
European Cash
NYSE Euronext European cash products ADV of 1.1 million transactions
in December 2012 decreased 20.2% compared to December 2011 and
decreased 8.7% compared to November 2012.
NYSE Euronext market share in European Cash products in December 2012
was 68.7%, up from 66.0% in December 2011 and up from 64.9% in
November 2012.
In the fourth quarter of 2012, European cash products market share was
66.5% with ADV of 1.2 million transactions which was 25.6% below prior
year levels.
For the full-year 2012, European cash products market share was 66.2%
with ADV of 1.4 million transactions which was 15.5% below prior year
levels.
U.S. Cash
NYSE Euronext U.S. cash products handled ADV in December 2012
decreased 14.7% to 1.5 billion shares compared to December 2011 and
decreased 3.4% from November 2012.
In the fourth quarter of 2012, U.S. cash products handled ADV was 1.6
billion shares, down 27.3% from prior year levels.
For the full-year 2012, U.S. cash products handled ADV was 1.7 billion
shares, down 26.2% from prior year levels.
NYSE Euronext’s Tape A matched market share in December 2012 was
31.9%, down from 33.4% in December 2011, but up from 31.7% in November
2012.
Exchange Traded Funds
NYSE Euronext U.S. matched exchange-traded funds ADV (included in
volumes for Tape B and Tape C) of 193 million shares in December 2012
decreased 22.1% compared to December 2011 and decreased 7.5% compared
to November 2012.
In the fourth quarter of 2012, NYSE Euronext U.S. matched
exchange-traded funds ADV of 197 million shares was 38.9% below prior
year levels.
For the full-year 2012, NYSE Euronext U.S. matched exchange-traded
funds ADV of 211 million shares was 34.9% below prior year levels.
Other Metrics
On October 5, 2012, NYSE Euronext closed on the public offering of
$850 million 2.00% notes due in October 2017. The proceeds from this
offering were used to fund the purchase of $336 million of our
outstanding $750 million 4.80% notes due in June 2013 and €80 million
of our €1 billion 5.375% notes due in June 2015 and for other general
corporate purposes, including the reduction in outstanding commercial
paper. As a result of the refinancing, interest expense is expected to
decline by approximately $1 million in the fourth quarter of 2012,
excluding a $24 million one-time charge for the refinancing which will
be excluded from fourth quarter 2012 non-GAAP financial results. The
refinancing is expected to save an annualized $15 million and $24
million in interest expense in 2013 and 2014, respectively.
The average EUR/USD exchange rate for the fourth quarter of 2012 of
$1.30 represented an increase of 3.7% from the third quarter of 2012
and a decrease of 3.8% compared to the fourth quarter of 2011. The
average GBP/USD exchange rate for the fourth quarter of 2012 of $1.61
represented an increase of 1.6% from the third quarter of 2012 and an
increase of 2.1% compared to the fourth quarter of 2011.
During the fourth quarter of 2012, a total of 1.1 million shares were
repurchased at an average price of $24.67. As a result of these
repurchases, the weighted average diluted shares outstanding in the
fourth quarter of 2012 was 245 million shares.
Please click
here for the Monthly Transaction Activity Data Table.
About NYSE Euronext
NYSE Euronext (NYX) is a leading global operator of financial markets
and provider of innovative trading technologies. The company's exchanges
in Europe and the United States trade equities, futures, options,
fixed-income and exchange-traded products. With approximately 8,000
listed issues (excluding European Structured Products), NYSE Euronext's
equities markets - the New York Stock Exchange, NYSE Euronext, NYSE MKT,
NYSE Alternext and NYSE Arca - represent one-third of the world’s
equities trading, the most liquidity of any global exchange group. NYSE
Euronext also operates NYSE Liffe, one of the leading European
derivatives businesses and the world's second-largest derivatives
business by value of trading. The company offers comprehensive
commercial technology, connectivity and market data products and
services through NYSE Technologies. NYSE Euronext is in the S&P 500
index. For more information, please visit: http://www.nyx.com.
Forward-Looking Statements
This press release may contain “forward-looking statements” made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. In some cases, you can identify
forward-looking statements by words such as “may,” “hope,” “will,”
“should,” “expect,” “plan,” “anticipate,” “intend,” “believe,”
“estimate,” “predict,” “potential,” “continue,” “could,” “future” or the
negative of those terms or other words of similar meaning. You should
carefully read forward-looking statements, including statements that
contain these words, because they discuss our future expectations or
state other “forward-looking” information. Forward-looking statements
involve a number of risks and uncertainties. ICE and NYSE Euronext
caution readers that any forward-looking statement is not a guarantee of
future performance and that actual results could differ materially from
those contained in the forward-looking statement. Such forward-looking
statements include, but are not limited to, statements about the
benefits of the proposed merger involving ICE and NYSE Euronext,
including future financial results, ICE’s and NYSE Euronext’s plans,
objectives, expectations and intentions, the expected timing of
completion of the transaction and other statements that are not
historical facts. Important factors that could cause actual results to
differ materially from those indicated by such forward-looking
statements are set forth in ICE’s and NYSE Euronext’s filings with the
U.S. Securities and Exchange Commission (the “SEC”). These risks and
uncertainties include, without limitation, the following: the inability
to close the merger in a timely manner; the inability to complete the
merger due to the failure of NYSE Euronext stockholders to adopt the
merger agreement or the failure of ICE stockholders to approve the
issuance of ICE common stock in connection with the merger; the failure
to satisfy other conditions to completion of the merger, including
receipt of required regulatory and other approvals; the failure of the
proposed transaction to close for any other reason; the possibility that
any of the anticipated benefits of the proposed transaction will not be
realized; the risk that integration of NYSE Euronext’s operations with
those of ICE will be materially delayed or will be more costly or
difficult than expected; the challenges of integrating and retaining key
employees; the effect of the announcement of the transaction on ICE’s,
NYSE Euronext’s or the combined company’s respective business
relationships, operating results and business generally; the possibility
that the anticipated synergies and cost savings of the merger will not
be realized, or will not be realized within the expected time period;
the possibility that the merger may be more expensive to complete than
anticipated, including as a result of unexpected factors or events;
diversion of management’s attention from ongoing business operations and
opportunities; general competitive, economic, political and market
conditions and fluctuations; actions taken or conditions imposed by the
United States and foreign governments and regulatory authorities; and
adverse outcomes of pending or threatened litigation or government
investigations. In addition, you should carefully consider the risks and
uncertainties and other factors that may affect future results of the
combined company described in the section entitled “Risk Factors” in the
joint proxy statement/prospectus to be delivered to ICE’s and NYSE
Euronext’s respective shareholders, and in ICE’s and NYSE Euronext’s
respective filings with the SEC that are available on the SEC’s web site
located at www.sec.gov,
including the sections entitled “Risk Factors” in ICE’s Form 10−K for
the fiscal year ended December 31, 2011, as filed with the SEC on
February 8, 2012, and ICE's Quarterly Reports on Form 10-Q for the
quarters ended June 30, 2012, as filed with the SEC on August 1, 2012
and September 30, 2012, as filed with the SEC on November 5, 2012, and
“Risk Factors” in NYSE Euronext’s Form 10−K for the fiscal year ended
December 31, 2011, as filed with the SEC on February 29, 2012. You
should not place undue reliance on forward-looking statements, which
speak only as of the date of this press release. Except for any
obligations to disclose material information under the Federal
securities laws, NYSE Euronext undertakes no obligation to publicly
update any forward-looking statements to reflect events or circumstances
after the date of this press release.
Important Information About the Proposed Transaction and Where to
Find It:
In connection with the proposed transaction, ICE intends to file with
the SEC a registration statement on Form S−4, which will include a joint
proxy statement/prospectus with respect to the proposed acquisition of
NYSE Euronext. The final joint proxy statement/prospectus will be
delivered to the stockholders of ICE and NYSE Euronext. Investors and
security holders of both ICE and NYSE Euronext are urged to read the
joint proxy statement/prospectus regarding the proposed transaction
carefully and in its entirety, including any documents previously filed
with the SEC and incorporated by reference into the joint proxy
statement/prospectus, when it becomes available because it will contain
important information regarding ICE, NYSE Euronext and the proposed
merger. Investors will be able to obtain a free copy of the joint proxy
statement/prospectus, as well as other filings containing information
about ICE and NYSE Euronext, without charge, at the SEC’s website at http://www.sec.gov/.
Investors may also obtain these documents, without charge, from ICE’s
website at http://www.theice.com.
Participants in the Merger Solicitation:
ICE, NYSE Euronext and their respective directors, executive officers
and other members of management and employees may be deemed to be
participants in the solicitation of proxies in respect of the
transactions contemplated by the merger agreement.
You can find information about ICE and ICE’s directors and executive
officers in ICE’s Annual Report on Form 10-K for the year ended December
31, 2011, as filed with the SEC on February 8, 2012, and ICE’s proxy
statement for its 2012 annual meeting of stockholders, as filed with the
SEC on March 30, 2012.
You can find information about NYSE Euronext and NYSE Euronext’s
directors and executive officers in NYSE Euronext’s Annual Report on
Form 10-K for the year ended December 31, 2011, as filed with the SEC on
February 29, 2012, and NYSE Euronext’s proxy statement for its 2012
annual meeting of stockholders, filed with the SEC on March 26, 2012.
Additional information about the interests of potential participants
will be included in the joint proxy statement/prospectuses, if and when
it becomes available, and the other relevant documents filed by ICE and
NYSE Euronext with the SEC.
This announcement does not constitute and offer or any solicitation of
any offer, to buy or subscribe for any securities.
1 All NYSE Euronext derivatives transactions count buy and
sell orders together as a single transaction. NYSE Euronext European
equities transactions count each buy and sell order as separate
transactions, NYSE Euronext U.S. equities transactions count buy and
sell orders together as a single transaction.
NYSE Euronext
Monthly Volume Summary
Average Daily Volume
Total Volume
Average Daily Volume
Total Volume
(Unaudited; contracts in thousands)
Dec-12
Dec-11
% Chg
Dec-12
Dec-11
% Chg
YTD 2012
% Chg vs.
YTD 2011
YTD 2012
% Chg vs.
YTD 2011
Number of Trading Days - European Cash
19
21
19
21
256
256
Number of Trading Days - European Derivatives
19
21
19
21
257
257
Number of Trading Days - U.S. Markets
20
21
20
21
250
250
European Derivatives Products
3,491
3,440
1.5%
66,326
72,245
-8.2%
3,719
-16.8%
955,802
-16.8%
of which Bclear
1,103
1,240
-11.1%
20,949
26,046
-19.6%
1,103
-3.3%
283,554
-3.3%
Total Fixed Income Products
1,587
1,352
17.4%
30,146
28,390
6.2%
1,754
-22.0%
450,896
-22.0%
Short Term Interest Rate Products
1,468
1,268
15.8%
27,897
26,625
4.8%
1,602
-24.1%
411,806
-24.1%
Medium and Long Term Interest Rate Products 1
118
84
40.8%
2,249
1,766
27.4%
152
9.5%
39,089
9.5%
Total Equity Products 2
1,807
2,021
-10.6%
34,335
42,432
-19.1%
1,875
-12.3%
481,969
-12.3%
Individual Equity Products
1,296
1,529
-15.2%
24,626
32,109
-23.3%
1,398
-10.4%
359,382
-10.4%
Futures
907
1,056
-14.0%
17,241
22,168
-22.2%
959
-1.6%
246,542
-1.6%
Options
389
473
-17.9%
7,385
9,941
-25.7%
439
-25.1%
112,841
-25.1%
Equity Index Products
511
492
3.9%
9,709
10,323
-6.0%
477
-17.5%
122,587
-17.5%
of which Bclear
1,103
1,240
-11.1%
20,949
26,046
-19.6%
1,103
-3.3%
283,554
-3.3%
Individual Equity Products
983
1,142
-14.0%
18,671
23,986
-22.2%
1,027
-3.1%
263,840
-3.1%
Futures
907
1,055
-14.0%
17,241
22,165
-22.2%
938
-2.2%
240,967
-2.2%
Options
75
87
-13.2%
1,430
1,820
-21.4%
89
-11.9%
22,873
-11.9%
Equity Index Products
120
98
22.2%
2,278
2,060
10.6%
77
-5.5%
19,714
-5.5%
Commodity Products
97
68
43.3%
1,844
1,422
29.7%
89
10.6%
22,937
10.6%
U.S. Derivatives Products
Equity Options 3
NYSE Euronext Options Contracts
3,888
3,936
-1.2%
77,767
82,656
-5.9%
3,893
-11.6%
973,140
-12.3%
Total Consolidated Options Contracts
14,275
14,224
0.4%
285,492
298,702
-4.4%
14,727
-12.2%
3,681,821
-12.8%
NYSE Group Share of Total
27.2%
27.7%
27.2%
27.7%
26.4%
0.1%
26.4%
0.1%
NYSE Liffe U.S.
Futures and Futures Options Volume*
72.6
89.6
-19.0%
1,452
1,882
-22.8%
72.7
-10.4%
18,769.2
-10.4%
European Cash Products (trades in thousands)
1,068
1,338
-20.2%
20,297
28,095
-27.8%
1,445
-15.5%
370,013
-15.9%
Equities
1,026
1,287
-20.2%
19,503
27,023
-27.8%
1,396
-15.1%
357,365
-15.4%
Exchange-Traded Funds
12
15
-25.0%
221
325
-32.1%
13
-35.0%
3,412
-35.2%
Structured Products
24
31
-20.9%
459
642
-28.4%
31
-25.7%
7,885
-26.0%
Bonds
6
5
20.5%
114
104
9.0%
5
5.8%
1,350
5.3%
U.S. Cash Products (shares in millions) 5
1,531
1,794
-14.7%
30,623
37,682
-18.7%
1,685
-26.2%
421,338
-26.8%
NYSE Listed (Tape A) Issues 4
Handled Volume 5
1,110
1,277
-13.1%
22,196
26,821
-17.2%
1,207
-24.9%
301,769
-25.5%
Matched Volume 6
1,068
1,212
-11.8%
21,363
25,445
-16.0%
1,147
-24.7%
286,785
-25.3%
Total NYSE Listed Consolidated Volume
3,353
3,623
-7.4%
67,069
76,086
-11.9%
3,659
-16.3%
914,654
-16.9%
Share of Total Consolidated Volume
Handled Volume 5
33.1%
35.3%
-2.2%
33.1%
35.3%
-2.2%
33.0%
-3.8%
33.0%
-3.8%
Matched Volume 6
31.9%
33.4%
-1.5%
31.9%
33.4%
-1.5%
31.4%
-3.5%
31.4%
-3.5%
NYSE Arca, MKT and Regional (Tape B) Listed Issues
Handled Volume 5
225
295
-23.7%
4,501
6,192
-27.3%
248
-35.0%
61,957
-35.5%
Matched Volume 6
209
263
-20.6%
4,171
5,517
-24.4%
225
-34.6%
56,127
-35.1%
Total NYSE Arca & MKT Listed Consolidated Volume
970
1,170
-17.1%
19,403
24,580
-21.1%
1,055
-28.4%
263,832
-29.0%
Share of Total Consolidated Volume
Handled Volume 5
23.2%
25.2%
-2.0%
23.2%
25.2%
-2.0%
23.5%
-2.4%
23.5%
-2.4%
Matched Volume 6
21.5%
22.4%
-0.9%
21.5%
22.4%
-0.9%
21.3%
-2.0%
21.3%
-2.0%
Nasdaq Listed (Tape C) Issues
Handled Volume 5
196
222
-11.7%
3,926
4,669
-15.9%
230
-21.8%
57,612
-22.4%
Matched Volume 6
175
189
-7.5%
3,506
3,979
-11.9%
199
-21.6%
49,756
-22.2%
Total Nasdaq Listed Consolidated Volume
1,689
1,615
4.6%
33,776
33,911
-0.4%
1,749
-13.5%
437,168
-14.2%
Share of Total Consolidated Volume
Handled Volume 5
11.6%
13.8%
-2.2%
11.6%
13.8%
-2.2%
13.2%
-1.4%
13.2%
-1.4%
Matched Volume 6
10.4%
11.7%
-1.3%
10.4%
11.7%
-1.3%
11.4%
-1.2%
11.4%
-1.2%
Exchange-Traded Funds 5,7
Handled Volume 5
208
279
-25.3%
4,166
5,854
-28.8%
233
-35.4%
58,195
-35.9%
Matched Volume 6
193
248
-22.1%
3,858
5,202
-25.8%
211
-34.9%
52,682
-35.5%
Total ETF Consolidated Volume
929
1,139
-18.5%
18,575
23,917
-22.3%
1,020
-28.2%
255,004
-28.7%
Share of Total Consolidated Volume
Handled Volume 5
22.4%
24.5%
-2.1%
22.4%
24.5%
-2.1%
22.8%
-2.5%
22.8%
-2.5%
Matched Volume 6
20.8%
21.7%
-0.9%
20.8%
21.7%
-0.9%
20.7%
-2.1%
20.7%
-2.1%
1
Data includes currency products.
2
Includes all trading activities for Bclear, NYSE Liffe's clearing
service for wholesale derivatives.
3
Includes trading in U.S. equity options contracts, not equity-index
options.
4
Includes all volume executed in NYSE Group crossing sessions.
5
Represents the total number of shares of equity securities and ETFs
internally matched on the NYSE Group's exchanges or routed to and
executed at an external market center. NYSE Arca routing includes
odd-lots.
6
Represents the total number of shares of equity securities and ETFs
executed on the NYSE Group's exchanges.
7
Data included in previously identified categories.
*
ADVs calculated with the appropriate number of NYSE Liffe U.S.
trading days.
Source: NYSE Euronext, Options Clearing Corporation and Consolidated
Tape as reported for equity securities.
All trading activity is single-counted, except European cash trading
which is double counted to include both buys and sells.
SYS-CON Events announced today that OpenStack will exhibit at SYS-CON's 12th International Cloud Expo, which will take place on June 10–13, 2013, at the Javits Center in New York City, New York. OpenStack software controls large pools of compute, storage, and networking resources thro...
In my recent article, "Five Steps to Improve E-Commerce Performance for Increased Sales: Introduction” I discussed problems encountered by our client TescaraHats (name changed for commercial reasons), a European market leader in manufacturing customized hats. The company quickly realiz...
Many have heard of OAuth but are unsure of how it might apply to their business.
In his session at the 12th International Cloud Expo, Alistair Farquharson, CTO of SOA Software, will describe how OAuth can be used to facilitate certain business models and simplify the sharing of priva...
“Cloud has everything to do with what has happened with Big Data,” explained Jason Deck, Director of Strategic Alliances at Logicworks, in this exclusive Q&A with Cloud Expo Conference Chair Jeremy Geelan. “Big Data doesn’t exist in its easily accessible way without cloud. From reduced...
SYS-CON Events announced today that nfina Technologies, a provider of highly reliable cloud server products, will exhibit at SYS-CON's 12th International Cloud Expo, which will take place on June 10–13, 2013, at the Javits Center in New York City, New York.
nfina Technologies develops...
It turns out cloud computing could be the most useful sales associate on the floor, and you won't have to worry about it stealing sales leads, ala “Glengarry Glen Ross.”
With the help of cloud computing, some brick-and-mortar stores are combating showrooming, a trend where consumers l...
.gif)
SYS-CON Events announced today that OpenStack will exhibit at SYS-CON's 12th International Cloud Expo, which will take place on June 10–13, 2013, at the Javits Center in New York City, New York. OpenStack software controls large pools of compute, storage, and networking resources thro...
In my recent article, "Five Steps to Improve E-Commerce Performance for Increased Sales: Introduction” I discussed problems encountered by our client TescaraHats (name changed for commercial reasons), a European market leader in manufacturing customized hats. The company quickly realiz...
Many have heard of OAuth but are unsure of how it might apply to their business.
In his session at the 12th International Cloud Expo, Alistair Farquharson, CTO of SOA Software, will describe how OAuth can be used to facilitate certain business models and simplify the sharing of priva...
“Cloud has everything to do with what has happened with Big Data,” explained Jason Deck, Director of Strategic Alliances at Logicworks, in this exclusive Q&A with Cloud Expo Conference Chair Jeremy Geelan. “Big Data doesn’t exist in its easily accessible way without cloud. From reduced...
SYS-CON Events announced today that nfina Technologies, a provider of highly reliable cloud server products, will exhibit at SYS-CON's 12th International Cloud Expo, which will take place on June 10–13, 2013, at the Javits Center in New York City, New York.
nfina Technologies develops...
It turns out cloud computing could be the most useful sales associate on the floor, and you won't have to worry about it stealing sales leads, ala “Glengarry Glen Ross.”
With the help of cloud computing, some brick-and-mortar stores are combating showrooming, a trend where consumers l...
